EUCTR2008-006742-26-IT进行中（未招募）不适用
Evaluation Study of a New Management Strategy for Gastroesophageal Reflux Disease (GERD) - GMP
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- ASTRAZENECA
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Signed and dated informed consent will be obtained before any study related procedure is conducted. 2.Male or female aged ≥ 18years. 3.Patients presenting with symptoms suggestive of typical GERD (heartburn or regurgitation as prevailing symptoms) of any severity and frequency: a.New diagnosis or symptom relapse b.No treatment with PPIs or H2 antagonists or a maximum of two doses a week in the past two weeks, allowing treatment with antacids. 4.Patient able to understand and complete the questionnaire.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.Documented medical history or gastrointestinal pathology such as:
- •-Gastrointestinal malignancy
- •-Zollinger-Ellison syndrome; malabsorption
- •-Significant cardiovascular, pulmonary, renal, pancreatic or liver disease as judged by the Investigator to interfere with the evaluation of the study
- •-Unstable diabetes mellitus as judged by the Investigator to interfere with the evaluation of the study. 2.Documented upper gastrointestinal surgery such as gastric resection, vagotomy and/or pyloroplasty, hiatus hernia surgery or fundoplication. Note: Previous lower gastrointestinal surgery such as appendectomy, colonic resection, cholecystectomy, or gynaecological surgery are not exclusion criteria. 3.Presence of Irritable Bowel Syndrome. This is characterised by chronic or recurrent abdominal pain associated with a chronic or recurrent bowel disturbance and/or bloating, that in the opinion of the investigator is likely to be due to the irritable bowel syndrome or two or more of the following criteria. -Visible abdominal distension -Pain relieved by a bowel action -More frequent stools with the onset of pain -Looser stools with onset of pain -Rectal passage of mucus -A sensation of incomplete defecation 4.Presence of any alarm symptoms suggestive of organic disease, including but not limited to, vomiting, GI bleeding or anaemia, abdominal mass, unexplained weight loss and dysphagia. 5.Severe, concurrent mental illness that may complicate the study evaluation or affect subject compliance as judged by the Investigator. 6.Requirement for continuous concurrent therapy with the following medications during the study period: -sucralrate -quinidine -warfarin and other vitamin K antagonists -phenytoin -biphosphonates -methotrexate -antidepressants (therapy less than 3 days per week is acceptable) -prostaglandin analogues such as misoprostol -ketoconazole, fluconazole, itraconazole -diazepam -cisapride -NSAIDs -aspirin >300mg/day 7.Pregnancy or lactation. Women of childbearing potential must have a negative pregnancy test and maintain contraception during the study medication treatment period. Investigators should be satisfied that those women who are not surgically sterilized or are < 1 year post-menopausal are not pregnant at study entry. 8.Chronic alcoholism, drug abuse, or psychological condition judged by the PCP to potentially result in poor subject compliance or interfere with study evaluation. 9.Suspected or confirmed current malignancy except basal cell carcinoma. Current is defined as: any malignancy, expect basal cell carcinoma, that has been active within the previous 12 months. 10.Known hypersensitivity to PPIs or any of their constituents. 11.Participation in a clinical study during the last 90 days.
研究者
相似试验
尚未招募
Unknown
pva reviewPatients who need to be connected to a ventilator due to breathing problems or other problems.IRCT20231001059572N1Ahvaz University of Medical Sciences60
已完成
不适用
Testing a new stepwise strategy for the management of renal anaemiaISRCTN72491207Guildford and Waverley CCG24
尚未招募
1 期
Study on the intervention and management model of metabolic syndrome with hyperuricemia based on ''state'' identification -- a cross-sectional study of metabolic syndrome with hyperuricemiahyperuricemia, Metabolic syndrome, GoutITMCTR2022000047Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine
尚未招募
1 期
Study on the intervention and management model of metabolic syndrome complicated with hyperuricemia based on ''state'' identification --Study on comprehensive intervention in acute stage of metabolic syndrome complicated with goutMetabolic syndrome\GoutITMCTR2022000046Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine
招募中
不适用
Evaluating the implementation of a new approach to preventive care provided by community mental health services to people with a mental health conditioObesityACTRN12621000922875niversity of Newcastle720